Vistin Pharma ASA's Board of Directors has approved an additional ordinary cash dividend of NOK 0.50 per share to be paid in November 2026. The dividend will be paid around November 27, with the last day to hold shares for the dividend on November 23. This payout follows authorization from the Annual General Meeting held on May 20, 2026. Investors should note the key dates to ensure eligibility for the dividend payment.
Vistin Pharma ASA's announcement of an additional cash dividend is timely context for health sector investors. For readers following health stocks, here is Pluang's market snapshot as of Oct 29, 2026 12:51 WIB: out of 150 priced US health stocks, 104 rose and 43 fell today. Notable movers include CTXR at USD 0.54 with a 6.10% increase and 95% sell order activity, TDOC at USD 7.29 up 5.96%, and GSK at USD 48.48 down 4.83% with 100% buy order activity and a typical hold time of 94 days on Pluang.
TGS ASA announced that its shares will be traded ex-dividend at NOK 1.45 per share starting October 29, 2026. This means investors buying the stock from this date will not receive the upcoming dividend payment. The dividend distribution follows appro...
DNO ASA, a Norwegian oil and gas company, announced a cash dividend of NOK 0.375 per share to be paid around November 17, 2026. Shareholders registered by November 9, 2026, will receive the dividend, with shares trading ex-dividend starting November ...
Shell plc posted strong third quarter 2026 results with adjusted earnings of $10.8 billion, driven by robust operational performance despite global energy disruptions. Key highlights include record refining margins, higher gas and LNG prices, and str...
Evotec SE, a life science company specializing in drug discovery and development, will release its financial results for the first nine months of 2026 on November 5, 2026. The company will host a webcast and conference call in English to provide a bu...
Shell plc announced strong third quarter 2026 results with net income attributable to shareholders reaching $12.1 billion, nearly doubling from Q3 2025. The performance was driven by higher refining margins, increased LNG prices, and the acquisition ...
